1. Home
  2. HSIC vs TECH Comparison

HSIC vs TECH Comparison

Compare HSIC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSIC
  • TECH
  • Stock Information
  • Founded
  • HSIC 1932
  • TECH 1976
  • Country
  • HSIC United States
  • TECH United States
  • Employees
  • HSIC N/A
  • TECH N/A
  • Industry
  • HSIC Medical Specialities
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HSIC Health Care
  • TECH Health Care
  • Exchange
  • HSIC Nasdaq
  • TECH Nasdaq
  • Market Cap
  • HSIC 8.1B
  • TECH 7.9B
  • IPO Year
  • HSIC 1995
  • TECH 1989
  • Fundamental
  • Price
  • HSIC $70.54
  • TECH $51.61
  • Analyst Decision
  • HSIC Buy
  • TECH Buy
  • Analyst Count
  • HSIC 10
  • TECH 10
  • Target Price
  • HSIC $79.30
  • TECH $73.44
  • AVG Volume (30 Days)
  • HSIC 1.4M
  • TECH 2.3M
  • Earning Date
  • HSIC 05-05-2025
  • TECH 05-07-2025
  • Dividend Yield
  • HSIC N/A
  • TECH 0.62%
  • EPS Growth
  • HSIC 8.11
  • TECH N/A
  • EPS
  • HSIC 3.21
  • TECH 0.83
  • Revenue
  • HSIC $12,669,000,000.00
  • TECH $1,208,770,000.00
  • Revenue This Year
  • HSIC $4.32
  • TECH $8.19
  • Revenue Next Year
  • HSIC $3.51
  • TECH $8.61
  • P/E Ratio
  • HSIC $22.15
  • TECH $62.17
  • Revenue Growth
  • HSIC 1.75
  • TECH 4.72
  • 52 Week Low
  • HSIC $60.56
  • TECH $46.44
  • 52 Week High
  • HSIC $82.49
  • TECH $85.57
  • Technical
  • Relative Strength Index (RSI)
  • HSIC 62.85
  • TECH 49.54
  • Support Level
  • HSIC $65.86
  • TECH $46.77
  • Resistance Level
  • HSIC $71.33
  • TECH $54.40
  • Average True Range (ATR)
  • HSIC 1.89
  • TECH 2.03
  • MACD
  • HSIC 0.81
  • TECH 0.70
  • Stochastic Oscillator
  • HSIC 90.95
  • TECH 63.43

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: